Cargando…
Stroke Treatment With PAR-1 Agents to Decrease Hemorrhagic Transformation
Ischemic stroke is the most widespread cause of disability and a leading cause of death in developed countries. To date, the most potent approved treatment for acute stroke is recanalization therapy with thrombolytic drugs such as tissue plasminogen activator (rt-PA or tPA) or endovascular mechanica...
Autores principales: | Lyden, Patrick D., Pryor, Kent E., Minigh, Jennifer, Davis, Thomas P., Griffin, John H., Levy, Howard, Zlokovic, Berislav V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005555/ https://www.ncbi.nlm.nih.gov/pubmed/33790846 http://dx.doi.org/10.3389/fneur.2021.593582 |
Ejemplares similares
-
Hemorrhagic Transformation in Ischemic Stroke and the Role of Inflammation
por: Spronk, Elena, et al.
Publicado: (2021) -
Hemorrhagic Transformation After Ischemic Stroke: Mechanisms and Management
por: Hong, Ji Man, et al.
Publicado: (2021) -
Hemodynamics and Hemorrhagic Transformation After Endovascular Therapy for Ischemic Stroke
por: Silverman, Andrew, et al.
Publicado: (2020) -
MRI-Based Predictors of Hemorrhagic Transformation in Patients With Stroke Treated by Intravenous Thrombolysis
por: El Nawar, Rody, et al.
Publicado: (2019) -
Liver Fibrosis Is Associated With Hemorrhagic Transformation in Patients With Acute Ischemic Stroke
por: Yuan, Cheng-Xiang, et al.
Publicado: (2020)